Epigenetic resensitization to platinum in ovarian cancer - Wikidata - wikimedia - TriplyDB

Epigenetic resensitization to platinum in ovarian cancer

Epigenetic resensitization to platinum in ovarian cancer

http://www.wikidata.org/entity/Q36979382

about

Epigenetic therapy in gastrointestinal cancer: the right combination DNA Methylation and Chromatin Remodeling: The Blueprint of Cancer Epigenetics Epigenetic treatment of solid tumours: a review of clinical trials Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer Environmental Epigenetics: Crossroad between Public Health, Lifestyle, and Cancer Prevention Application of microRNA in diagnosis and treatment of ovarian cancer Cancer epigenetics drug discovery and development: the challenge of hitting the mark Rewriting the epigenetic code for tumor resensitization: a review.KRAS Genomic Status Predicts the Sensitivity of Ovarian Cancer Cells to Decitabine.Epigenetic polypharmacology: from combination therapy to multitargeted drugs Chemoresistance and targeted therapies in ovarian and endometrial cancers Carboplatin with Decitabine Therapy, in Recurrent Platinum Resistant Ovarian Cancer, Alters Circulating miRNAs Concentrations: A Pilot Study Cross platform analysis of methylation, miRNA and stem cell gene expression data in germ cell tumors highlights characteristic differences by tumor histology.Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA.Prognostic value of MLH1 promoter methylation in male patients with esophageal squamous cell carcinoma.Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat: a phase 2 consortium/stand up 2 cancer study.Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer.Impact of decitabine on immunohistochemistry expression of the putative tumor suppressor genes FHIT, WWOX, FUS1 and PTEN in clinical tumor samples.Decitabine reactivated pathways in platinum resistant ovarian cancer.Epigenetic targeting of ovarian cancer stem cells Gene body methylation can alter gene expression and is a therapeutic target in cancer.Episensitization: therapeutic tumor resensitization by epigenetic agents: a review and reassessment.The novel, small-molecule DNA methylation inhibitor SGI-110 as an ovarian cancer chemosensitizer.Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.Ovarian cancer stem cells: are they real and why are they important?Evaluation of azacitidine and entinostat as sensitization agents to cytotoxic chemotherapy in preclinical models of non-small cell lung cancer The promise of methylation on beads for cancer detection and treatment.Tackling the Cytotoxic Effect of a Marine Polycyclic Quinone-Type Metabolite: Halenaquinone Induces Molt 4 Cells Apoptosis via Oxidative Stress Combined with the Inhibition of HDAC and Topoisomerase Activities.Episensitization: Defying Time's Arrow Contributions of the Epidermal Growth Factor Receptor to Acquisition of Platinum Resistance in Ovarian Cancer Cells.Phage display screening identifies a novel peptide to suppress ovarian cancer cells in vitro and in vivo in mouse models.SGI-110: DNA Methyltransferase Inhibitor Oncolytic An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer.Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses Epigenetic synergy between decitabine and platinum derivatives Transmembrane protein 88 (TMEM88) promoter hypomethylation is associated with platinum resistance in ovarian cancer TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells.Immunomodulatory action of the DNA methyltransferase inhibitor SGI-110 in epithelial ovarian cancer cells and xenografts.Gene methylation of human ovarian carcinoma stromal progenitor cells promotes tumorigenesis

P2860

Q26745709-C68B4CED-76B2-4EBF-A31E-B0D858E015DC Q26749421-746DC11E-3A0C-4052-89E7-72C6029C2D48 Q26773803-1DCF3B2C-80E1-4880-B0CA-FD5C33985E99 Q26780387-DAD043CF-4F68-4072-8963-C808325DF22D Q26784500-13E1E3EB-653E-46E3-80C9-5A5108F58271 Q26991620-DB733231-9A12-42BF-BEC4-FCCF968EEAEB Q27002333-26C722E3-EC09-439B-8424-5DBC433F4CED Q27687583-9072AFBF-0879-4959-B4C4-DA098C90EBA9 Q27853164-6BB9A4F4-F7B4-4488-8F47-FA074B32F92D Q28067666-C803BB9A-5F22-477E-8307-41CCE75F3FAC Q28073246-C384D4C2-44DD-46F7-A4DF-001DB0D37C76 Q28550381-8DFAE2C6-9F3F-4F48-97E6-A3BEBE8471E0 Q31010344-E9A1FA2B-9DA1-4530-8BA7-9D38E4A1E34C Q33584143-D9849B91-BB3D-46B1-A81E-D98308939F0E Q33591552-544FA4B8-2046-4BA2-9AAE-E7E7BF2151B9 Q33598672-14C094F9-D4A8-4349-AEC8-9F13766A8B2F Q33798842-37188389-90D7-4F67-8712-C827164BA695 Q33827681-2DD09023-096B-43AA-A67F-A0BF1A8FDE6A Q33891538-B061A199-385E-4586-994E-CC806D2A086C Q33976957-E133C706-4E3D-4174-A378-C397AD89086C Q34135466-7F41E1F7-5298-49A0-8E76-74FE8BDEF967 Q34471361-C84B36D6-92C2-414E-AF0F-C325DD34C2F4 Q34676418-8B6D8478-48FD-48AA-9D1D-C2FFF9FE9801 Q34717933-55E93779-5F59-4A61-B618-6EDBDDB95A17 Q35000789-A73C6844-E3F2-4559-BFDD-302CF7DBE2F5 Q35047699-3CC03D8E-29E1-4041-94C3-0909C3F1AD22 Q35238397-96EF41F6-DF31-47DF-B9A8-6EF5708DC26A Q35594733-7AA25CCC-5A78-4874-9696-9744CA6488FD Q35640652-DD06C375-D17B-4D7F-BAE5-659657FE5DFE Q35726218-7F0EEDE2-4E75-45E7-928C-E6734CCAC1E8 Q35767493-2E548B08-4BB3-400E-AB8A-A68D38CE6266 Q35837404-0D61AB21-735F-4427-9BD6-79A516B0A5F0 Q35854709-1C30B41F-F254-4C16-BC1E-A9151B1A70D3 Q35941858-564B3AA6-1A80-486D-B3CE-900FEA8EA0A0 Q36015063-5F461F2D-2750-4AB6-B723-D514A89A6D34 Q36053915-4D32EA68-B2C6-4978-8EA9-7AF79C3D915D Q36067023-1FBE82AD-B9DB-40BB-811B-2F005B875FD1 Q36213724-305249AA-3F05-4DA9-AD10-DF55149D77D3 Q36214731-47AEC947-53EC-4C3B-B30B-199C42145502 Q36305814-AE1ED4A2-C160-4615-B903-6CFCE1AAC376

P2860

Epigenetic resensitization to platinum in ovarian cancer

http://www.wikidata.org/entity/Q36979382

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Epigenetic resensitization to platinum in ovarian cancer

@en

type

label

Epigenetic resensitization to platinum in ovarian cancer

@en

prefLabel

Epigenetic resensitization to platinum in ovarian cancer

@en

P1433

Q36979382-F4D54502-A296-4525-BB6C-08B9A358B333

P1476

Q36979382-CA18C91E-B95E-43D8-BE27-C1AD6D189880

P2093

Q36979382-27526E40-3DF2-4548-B372-896089FFF866

Q36979382-29EC9B3E-22CE-4957-AAEC-1773E2C0572F

Q36979382-93E003A9-8C35-455B-8D17-3B7571508BBD

Q36979382-BD4C342C-842D-4FFE-841D-7B6D81B4BEA3

Q36979382-D8D798DC-E177-47B4-8ED7-DA07E2A383D9

Q36979382-DDD538F9-92F2-4D0D-A16A-66EE8FCDA7C2

Q36979382-EC0413CB-9ABC-4790-843B-48558A91489A

Q36979382-F82CC563-6E1F-4C97-B4F7-C330FAA5F1DC

P2860

Q36979382-040F419F-E820-4E4F-AE9D-3D838D073152

Q36979382-0AC2D384-5BE9-417A-9E0A-F57D565ECE1D

Q36979382-0AE9D345-8D04-4F93-A405-CC523F606F99

Q36979382-1CAA4B99-0CE9-486E-9381-1CC01E8E6F36

Q36979382-1F84D68B-BC3C-4502-92AC-93CC3B2E1074

Q36979382-1F94B2F6-0974-4A42-8D37-BD55767A479A

Q36979382-22D8CE1F-4BBF-4095-BF07-AF037257D72A

Q36979382-241389FB-5E56-41E3-A770-DA0CEBB9E0CD

Q36979382-24D6F7D8-5430-442F-84B7-6E0BD4141837

Q36979382-30447C8C-87AF-4C18-9AAA-24F69CD94359

P304

Q36979382-E650DA5A-7C7A-49EE-8590-9A9B5E82367E

P31

Q36979382-7A24AECF-BD97-4233-BF14-F7CE2915B300

P356

Q36979382-F61F113E-4AAF-4E4C-B022-874389B7FA57

P407

Q36979382-065B5AE9-EA0B-4EEC-B44D-F8A36B2DFA9E

P433

Q36979382-61F6FC3F-CE29-4A4D-B2E3-7D617522327D

P478

Q36979382-8BEE1303-9895-4374-8BB4-7802CE569227

P50

Q36979382-096857C9-83C6-466A-8ED1-BFA21017135A

P577

Q36979382-63589DB9-7CF5-4036-A1BE-E7BC485F90A1

P698

Q36979382-5E6C9F6F-2B46-4A54-91A4-A18929D14E05

P921

Q36979382-EE3D7DCA-5C9E-4FD2-BB6E-AF143F6FFE07

P932

Q36979382-518DD77F-85DF-479C-BE7B-1BDF90971A74

P356

0008-5472.CAN-11-3909

P1433

Cancer Research

P1476

Epigenetic resensitization to platinum in ovarian cancer

@en

P2093

Alesha Arnold

http://www.w3.org/2001/XMLSchema#string

Changyu Shen

http://www.w3.org/2001/XMLSchema#string

Fang Fang

http://www.w3.org/2001/XMLSchema#string

Jeanne Schilder

http://www.w3.org/2001/XMLSchema#string

Kenneth P Nephew

http://www.w3.org/2001/XMLSchema#string

Tim Huang

http://www.w3.org/2001/XMLSchema#string

William A Berry

http://www.w3.org/2001/XMLSchema#string

Yan Zeng

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

The epigenomics of cancer

A novel requirement for Janus kinases as mediators of drug resistance induced by fibroblast growth factor-2 in human cancer cells

Global analysis of DNA methylation by Methyl-Capture sequencing reveals epigenetic control of cisplatin resistance in ovarian cancer cell

MAP kinase signalling pathways in cancer

A phase I trial of cisplatin plus decitabine, a new DNA-hypomethylating agent, in patients with advanced solid tumors and a follow-up early phase II evaluation in patients with inoperable non-small cell lung cancer.

Evaluation of a 7-day continuous intravenous infusion of decitabine: inhibition of promoter-specific and global genomic DNA methylation.

Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer

An epigenetic signature in peripheral blood predicts active ovarian cancer

P304

2197-2205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-11-3909

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22549947

http://www.w3.org/2001/XMLSchema#string

P921

P932

3700422

http://www.w3.org/2001/XMLSchema#string